{
  "pmcid": "11895797",
  "sha256": "4a126750cb2747e0ca132c4fccaa9df4e380c3a8107d93e01ae80f5ea2b31c40",
  "timestamp_utc": "2025-11-09T23:22:25.539494+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.26036048689139,
    "reading_ease": 26.976832865168547,
    "word_count": 267
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "A Randomised Controlled Trial Comparing Dexmedetomidine and Ketorolac for Postoperative Pain Management in Appendectomy"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "60 patients aged 18-65 years undergoing appendectomy were randomised into three groups"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligibility criteria included ASA class I and II, excluding those with allergies, drug use, or complicated appendicitis."
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised into three groups: dexmedetomidine (n=20), ketorolac (n=20), and control (n=20)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the preemptive/preventive effects of dexmedetomidine versus ketorolac on postoperative pain in appendectomy patients."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was VAS pain scores at 1, 3, 6, 12, and 24 hours postoperatively."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated with allocation concealment via sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding included patients, outcome assessors, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "60 patients aged 18-65 years undergoing appendectomy were randomised into three groups"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Dexmedetomidine group showed significantly lower VAS scores"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Dexmedetomidine group showed significantly lower VAS scores at 12 and 24 hours (1.15 ± 1.98 and 0.95 ± 1.76, P=0.004 and P=0.003) compared to ketorolac and control."
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: IRCT20140615018091N9"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}